Nasos Athanasiou

Nasos Athanasiou has extensive experience in the pharmaceutical and healthcare sectors, currently serving as the CEO of AVVA Pharmaceuticals since January 2016. Prior to this role, Nasos held the position of Business Development Director at AVVA Development Ltd from December 2014 to December 2015. Between November 2008 and November 2014, Nasos was the General Manager at Agetis Supplements, a subsidiary of Medochemie Ltd. Earlier career roles include Business Development Manager for the Pharmaceutical Division at CAP Papaellinas Ltd from February 2006 to December 2007, and Oncology & Critical Care Manager for Gulf & State Markets, as well as Marketing Coordinator for Cyprus, Malta, and Palestine at Eli Lilly and Company from October 2001 to November 2005. Nasos began the career as a Validation Engineer at Morton Grove Pharmaceuticals from January 2000 to January 2001.